Authors: GLASPY JA SHPALL EJ LEMAISTRE CF BRIDDELL RA MENCHACA DM TURNER SA LILL M CHAP L JONES R WIERS MD SHERIDAN WP MCNIECE IK

Citation: Ja. Glaspy et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION USING STEM-CELL FACTOR IN COMBINATION WITH FILGRASTIM IN BREAST-CANCER PATIENTS, Blood, 90(8), 1997, pp. 2939-2951

Authors: BASSER RL RASKO JEJ CLARKE K CEBON J GREEN MD GRIGG AP ZALCBERG J COHEN B OBYRNE J MENCHACA DM FOX RM BEGLEY CG

Citation: Rl. Basser et al., RANDOMIZED, BLINDED, PLACEBO-CONTROLLED PHASE-I TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR WITH FILGRASTIM AFTER DOSE-INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER, Blood, 89(9), 1997, pp. 3118-3128

Authors: COSTA JJ DEMETRI GD HARRIST TJ DVORAK AM HAYES DF MERICA EA MENCHACA DM GRINGERI AJ SCHWARTZ LB GALLI SJ

Citation: Jj. Costa et al., RECOMBINANT HUMAN STEM-CELL FACTOR (KIT-LIGAND) PROMOTES HUMAN MAST-CELL AND MELANOCYTE HYPERPLASIA AND FUNCTIONAL ACTIVATION IN-VIVO, The Journal of experimental medicine, 183(6), 1996, pp. 2681-2686

Authors: COSTA JJ DEMETRI GD HARRIST TJ DVORAK AM HAYES DF MERICA EA MENCHACA DM GRINGERI AJ GALLI SJ

Citation: Jj. Costa et al., RECOMBINANT HUMAN STEM-CELL FACTOR (RHSCF) INDUCES CUTANEOUS MAST-CELL ACTIVATION AND HYPERPLASIA, AND HYPERPIGMENTATION IN HUMANS IN-VIVO, Journal of allergy and clinical immunology, 93(1), 1994, pp. 225-225